Your browser doesn't support javascript.
loading
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain.
Casado, Luis Felipe; Burgos, Amparo; González-Haba, Eva; Loscertales, Javier; Krivasi, Tania; Orofino, Javier; Rubio-Terres, Carlos; Rubio-Rodríguez, Darío.
  • Casado LF; Hematology Department, Hospital Virgen de la Salud, Toledo, Spain.
  • Burgos A; Pharmacy Department, Hospital General Universitario de Alicante, Alicante, Spain.
  • González-Haba E; Pharmacy Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Loscertales J; Hematology Deparment, Hospital Universitario De La Princesa, Madrid, Spain.
  • Krivasi T; Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Orofino J; Roche Farma SA, Madrid, Spain.
  • Rubio-Terres C; Health Value, Madrid, Spain.
  • Rubio-Rodríguez D; Health Value, Madrid, Spain.
Clinicoecon Outcomes Res ; 8: 475-484, 2016.
Article en En | MEDLINE | ID: mdl-27703384
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Año: 2016 Tipo del documento: Article